<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04570033</url>
  </required_header>
  <id_info>
    <org_study_id>Military Institute of Medicine</org_study_id>
    <nct_id>NCT04570033</nct_id>
  </id_info>
  <brief_title>The Utility of 18F-fluorocholine PET/CT in the Imaging of Parathyroid Adenomas</brief_title>
  <official_title>The Utility of 18F-fluorocholine PET/CT in the Imaging of Parathyroid Adenomas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Military Institute of Medicine, Poland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Military Institute of Medicine, Poland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      We assessed sensitivity of 18F-FCH PET/CT in preoperative localisation of hyperfunctioning&#xD;
      parathyroid tissue in patients with primary hyperparathyroidism (PHPT).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We prospectively enrolled 65 consecutive patients with PHPT who underwent neck ultrasound&#xD;
      (US) and parathyroid scintigraphy (99mTc/99mTc-MIBI dual phase). Twenty-two patients had&#xD;
      unsuccessful parathyroid surgery prior to the study. PET/CT scans were performed 65.0 ± 13.3&#xD;
      min after injection of 218.5 ± 31.9 MBq of 18F-fluorocholine (FCH). Three experienced nuclear&#xD;
      medicine physicians assessed the detection rate of hyperfunctioning parathyroid tissue.&#xD;
      Response to parathyroidectomy and clinical follow-up served as a reference test. Per-patient&#xD;
      sensitivity and positive predictive value (PPV) were calculated for patients who underwent&#xD;
      surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">January 1, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The utility of 18F-fluorocholine PET/CT in the imaging of parathyroid adenomas</measure>
    <time_frame>24 months</time_frame>
    <description>Sensitivity and positive predictive value of 18F-FCH PET/CT in preoperative localisation of hyperfunctioning parathyroid tissue in patients with primary hyperparathyroidism</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Hyperparathyroidism</condition>
  <condition>Parathyroid Adenoma</condition>
  <arm_group>
    <arm_group_label>patients with hyperparathyroidism</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>We prospectively enrolled 65 consecutive patients with primary hyperparathyroidism (PHPT) who underwent neck ultrasound (US) and parathyroid scintigraphy (99mTc/99mTc-MIBI dual phase). Twenty-two patients had unsuccessful parathyroid surgery prior to the study</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>We assessed sensitivity of 18F-FCH PET/CT in preoperative localisation of hyperfunctioning parathyroid tissue in patients with primary hyperparathyroidism</intervention_name>
    <description>We prospectively enrolled 65 consecutive patients with PHPT who underwent neck ultrasound (US) and parathyroid scintigraphy (99mTc/99mTc-MIBI dual phase). Twenty-two patients had unsuccessful parathyroid surgery prior to the study. PET/CT scans were performed 65.0 ± 13.3 min after injection of 218.5 ± 31.9 MBq of 18F-fluorocholine (FCH). Three experienced nuclear medicine physicians assessed the detection rate of hyperfunctioning parathyroid tissue. Response to parathyroidectomy and clinical follow-up served as a reference test. Per-patient sensitivity and positive predictive value (PPV) were calculated for patients who underwent surgery.</description>
    <arm_group_label>patients with hyperparathyroidism</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  primary hyperparathyroidism and neck US and the dual-phase 99mTc/99mTc-MIBI SPECT/CT&#xD;
             scintigraphy performed prior to the PET/CT scan&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  patient's lack of consent to the examination&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrzej Mazurek, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Military Institute of Medicine</affiliation>
  </overall_official>
  <results_reference>
    <citation>Cordellat IM. Hyperparathyroidism: primary or secondary disease? Reumatol Clin. 2012 Sep-Oct;8(5):287-91. Epub 2011 Oct 20. Review.</citation>
    <PMID>22089066</PMID>
  </results_reference>
  <results_reference>
    <citation>Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, Doherty GM, Herrera MF, Pasieka JL, Perrier ND, Silverberg SJ, Solórzano CC, Sturgeon C, Tublin ME, Udelsman R, Carty SE. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-968. doi: 10.1001/jamasurg.2016.2310.</citation>
    <PMID>27532368</PMID>
  </results_reference>
  <results_reference>
    <citation>López-Mora DA, Sizova M, Estorch M, Flotats A, Camacho V, Fernández A, Abouzian S, Fuentes-Ocampo F, Garcia JIP, Ballesteros AIC, Duch J, Domènech A, Duarte AM, Carrió I. Superior performance of 18F-fluorocholine digital PET/CT in the detection of parathyroid adenomas. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):572-578. doi: 10.1007/s00259-020-04680-7. Epub 2020 Jan 9. Erratum in: Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1609.</citation>
    <PMID>31919634</PMID>
  </results_reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 21, 2020</study_first_submitted>
  <study_first_submitted_qc>September 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2020</study_first_posted>
  <last_update_submitted>September 25, 2020</last_update_submitted>
  <last_update_submitted_qc>September 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Military Institute of Medicine, Poland</investigator_affiliation>
    <investigator_full_name>Andrzej Mazurek</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>PET/CT</keyword>
  <keyword>fluorocholine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Parathyroid Neoplasms</mesh_term>
    <mesh_term>Hyperparathyroidism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parathyroid Hormone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

